BackVanguard Intermediate Term Tax-Exempt Fund Overview

Vanguard Intermediate Term Tax-Exempt Fund EBIT

Latest ebit for VWITX: $930K, above the sector sector average of $-6.4M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.00M
53.74% YoY

As of Oct 31, 2023

Annual EBIT (TTM)

$925.03K
104.03% YoY

Trailing 12 months ending Oct 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Vanguard Intermediate Term Tax-Exempt Fund (VWITX) FAQ

As of the most recent data (October 2023), VWITX shows a EBIT of $930K. That compares with $-23M in the prior-year period — up 104.0% year over year. That is above the sector sector average of $-6.4M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VWITX's EBIT is now $930K (was $-23M) — a 104.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Vanguard Intermediate Term Tax-Exempt Fund is outperforming or lagging.

The its sector sector average EBIT is about $-6.4M. Vanguard Intermediate Term Tax-Exempt Fund is at $930K, which is higher that average. That is roughly 114.4% above the sector mean. Use the comparison chart on this page to see how VWITX stacks up against individual peers as well.

Tracking VWITX's ebit over time shows whether Vanguard Intermediate Term Tax-Exempt Fund is scaling, shrinking, or reshaping that part of the business. The current reading is $930K That compares with $-23M in the prior-year period — up 104.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Vanguard Intermediate Term Tax-Exempt Fund's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $930K) with ownership activity and broader fundamentals.